Stjernquist M
Department of Obstetrics and Gynaecology, University Hospital MAS, S-205 02 Malmö, Sweden.
Cell Tissue Res. 1998 Apr;292(1):1-9. doi: 10.1007/s004410051028.
The endothelins (ETs) are regulatory peptides, distributed in many organ systems and with potent physiological effects. ETs represent the most powerful vasoconstrictive substances known today. They also act as growth factors and seem to be involved in fetal development. Much data support a pathophysiological role for ETs, especially in diseases of the vascular system, such as hypertension, preeclampsia, ischemic heart disease, subarachnoidal haemorrhage, and cerebral ischemia. The development of drugs affecting ET-receptors and the biosynthesis of ETs presently attract great interest for the establishment of new treatments of diseases in which ETs are involved. Hopefully, the elaboration of more specific ET-receptor ligands will fulfill some of these expectations.
内皮素(ETs)是一种调节肽,分布于多个器官系统,具有强大的生理效应。ETs是目前已知最强效的血管收缩物质。它们还作为生长因子发挥作用,似乎参与胎儿发育。大量数据支持ETs在病理生理学中的作用,尤其是在血管系统疾病中,如高血压、先兆子痫、缺血性心脏病、蛛网膜下腔出血和脑缺血。目前,影响ET受体和ET生物合成的药物研发对于建立涉及ETs疾病的新治疗方法引起了极大兴趣。有望研发出更具特异性的ET受体配体来满足其中一些期望。